Home | Business News | Browse by Publication | P | Pharma Marketletter

Ipsen and Galderma in botulinum toxin deal.

Publication: Pharma Marketletter
Publication Date: 05-MAR-07
Format: Online
Delivery: Immediate Online Access
Full Article Title: Ipsen and Galderma in botulinum toxin deal.(Galderma Laboratories Inc.)(Brief article)

Article Excerpt
French drugmaker Ipsen and specialty pharmaceutical group Galderma, which is co-owned by L'Oreal and Nestle, have entered into a partnership which will focus on the development, promotion and distribution of the former's botulinum type A toxin for use in asthetic medicine indications.

Under the terms of the deal, Ipsen...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Actavis acquires API unit of India's Sanmar.(Active Pharmaceutical Ing..., March 05, 2007
Azur completes purchase of Pharmelle.(Azur Pharma )(Brief article), March 05, 2007
Abbott's Humira cleared for CD in USA.(Abbott Laboratories (Abbott Par..., March 05, 2007
PPD licenses Ranbaxy's novel statin.(Pharmaceutical Product Developmen..., March 05, 2007
Accentia licenses global rights to Revimmune.(Brief article), March 05, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.